Sofinnova Ventures
Latest statistics and disclosures from Sofinnova Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NTRA, GILD, UTHR, VERA, JAZZ, and represent 36.52% of Sofinnova Investments's stock portfolio.
- Added to shares of these 10 stocks: UTHR (+$71M), VRTX (+$46M), AZN (+$41M), XBI (+$40M), AXSM (+$36M), GKOS (+$26M), GILD (+$22M), APGE (+$19M), ISRG (+$18M), DXCM (+$17M).
- Started 11 new stock positions in NKTR, GEHC, XBI, CELC, Imagenebio, Nextcure, GKOS, CMPX, VRTX, LQDA. ACAD.
- Reduced shares in these 10 stocks: LLY (-$76M), RYTM (-$57M), IWM (-$54M), QURE (-$36M), IDYA (-$33M), REPL (-$31M), INSM (-$30M), CDTX (-$28M), ABBV (-$27M), ANAB (-$24M).
- Sold out of its positions in IKNA, INZY, IWM, LLY, MTSR, NXTC, REPL, GPCR, SNDX, Y Mabs Therapeutics.
- Sofinnova Investments was a net seller of stock by $-151M.
- Sofinnova Investments has $1.8B in assets under management (AUM), dropping by 11.85%.
- Central Index Key (CIK): 0001631134
Tip: Access up to 7 years of quarterly data
Positions held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 59 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Natera (NTRA) | 13.6 | $250M | 1.6M | 160.97 |
|
|
| Gilead Sciences (GILD) | 7.6 | $139M | +19% | 1.3M | 111.00 |
|
| United Therapeutics Corporation Put Option (UTHR) | 6.6 | $121M | +142% | 288k | 419.21 |
|
| Vera Therapeutics Cl A (VERA) | 4.4 | $81M | 2.8M | 29.06 |
|
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 4.2 | $78M | -15% | 589k | 131.80 |
|
| AstraZeneca Sponsored Adr (AZN) | 3.5 | $63M | +180% | 824k | 76.72 |
|
| Rapport Therapeutics (RAPP) | 3.2 | $58M | -2% | 1.9M | 29.70 |
|
| Boston Scientific Corporation (BSX) | 3.0 | $56M | +32% | 569k | 97.63 |
|
| Uniqure NV SHS Call Option (QURE) | 3.0 | $55M | -39% | 937k | 58.37 |
|
| Dex (DXCM) | 2.9 | $53M | +48% | 780k | 67.29 |
|
| Intuitive Surgical (ISRG) | 2.7 | $50M | +56% | 111k | 447.23 |
|
| Axsome Therapeutics (AXSM) | 2.6 | $48M | +320% | 394k | 121.45 |
|
| Roivant Sciences SHS (ROIV) | 2.6 | $48M | -22% | 3.1M | 15.13 |
|
| iShares TR Ishares Biotech Put Option (IBB) | 2.6 | $47M | -13% | 325k | 144.37 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $46M | NEW | 118k | 391.64 |
|
| Bridgebio Pharma (BBIO) | 2.4 | $43M | -16% | 832k | 51.94 |
|
| SPDR Series Trust S&p Biotech Put Option (XBI) | 2.2 | $40M | NEW | 400k | 100.20 |
|
| Avidity Biosciences Ord (RNA) | 2.1 | $38M | +49% | 876k | 43.57 |
|
| Abbvie (ABBV) | 1.9 | $35M | -43% | 151k | 231.54 |
|
| Arrivent Biopharma (AVBP) | 1.7 | $31M | 1.7M | 18.45 |
|
|
| Cogent Biosciences (COGT) | 1.7 | $31M | -29% | 2.1M | 14.36 |
|
| Glaukos (GKOS) | 1.4 | $26M | NEW | 313k | 81.55 |
|
| Ideaya Biosciences (IDYA) | 1.4 | $25M | -57% | 923k | 27.21 |
|
| Rhythm Pharmaceuticals (RYTM) | 1.4 | $25M | -69% | 247k | 100.99 |
|
| Akero Therapeutics (AKRO) | 1.2 | $23M | -13% | 474k | 47.48 |
|
| Apogee Therapeutics (APGE) | 1.2 | $23M | +642% | 565k | 39.73 |
|
| EXACT Sciences Corporation (EXAS) | 1.1 | $20M | +75% | 365k | 54.71 |
|
| Immatics SHS (IMTX) | 1.0 | $19M | 2.2M | 8.52 |
|
|
| Summit Therapeutics Call Option (SMMT) | 1.0 | $19M | +28% | 900k | 20.66 |
|
| Pharvaris N V (PHVS) | 1.0 | $19M | +26% | 740k | 24.95 |
|
| Supernus Pharmaceuticals (SUPN) | 1.0 | $18M | -52% | 377k | 47.79 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $17M | 1.2M | 13.60 |
|
|
| Merus N V (MRUS) | 0.9 | $16M | -58% | 167k | 94.15 |
|
| Insmed Com Par $.01 (INSM) | 0.8 | $15M | -66% | 104k | 144.01 |
|
| Inhibrx Biosciences (INBX) | 0.8 | $15M | -37% | 440k | 33.68 |
|
| Bioage Labs (BIOA) | 0.7 | $14M | 2.3M | 5.88 |
|
|
| Celcuity (CELC) | 0.7 | $13M | NEW | 253k | 49.40 |
|
| Dyne Therapeutics (DYN) | 0.7 | $13M | +60% | 986k | 12.65 |
|
| Ptc Therapeutics I (PTCT) | 0.6 | $12M | -50% | 187k | 61.37 |
|
| Ge Healthcare Technologies I (GEHC) | 0.6 | $11M | NEW | 151k | 75.10 |
|
| Soleno Therapeutics (SLNO) | 0.6 | $11M | -59% | 166k | 67.60 |
|
| Praxis Precision Medicines I (PRAX) | 0.5 | $9.2M | +999% | 173k | 53.00 |
|
| Savara (SVRA) | 0.5 | $8.7M | 2.4M | 3.57 |
|
|
| Edgewise Therapeutics (EWTX) | 0.5 | $8.4M | -27% | 520k | 16.22 |
|
| Anaptysbio Inc Common (ANAB) | 0.4 | $7.8M | -75% | 254k | 30.62 |
|
| Compass Therapeutics (CMPX) | 0.4 | $7.1M | NEW | 2.0M | 3.50 |
|
| Nektar Therapeutics (NKTR) | 0.4 | $6.7M | NEW | 118k | 56.90 |
|
| Liquidia Technologies Put Option (LQDA) | 0.3 | $5.7M | NEW | 250k | 22.74 |
|
| Cidara Therapeutics (CDTX) | 0.3 | $5.2M | -84% | 54k | 95.76 |
|
| Immunome (IMNM) | 0.3 | $5.1M | -43% | 436k | 11.71 |
|
| Nextcure | 0.1 | $1.3M | NEW | 223k | 5.86 |
|
| Wave Life Sciences SHS (WVE) | 0.1 | $1.3M | +44% | 171k | 7.32 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $1.2M | +18% | 31k | 37.24 |
|
| Jade Biosciences (JBIO) | 0.1 | $927k | 107k | 8.63 |
|
|
| Disc Medicine (IRON) | 0.0 | $896k | +85% | 14k | 66.08 |
|
| Bolt Biotherapeutics (BOLT) | 0.0 | $733k | 138k | 5.32 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $572k | NEW | 27k | 21.34 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.0 | $442k | -61% | 11k | 40.99 |
|
| Imagenebio | 0.0 | $260k | NEW | 32k | 8.15 |
|
Past Filings by Sofinnova Investments
SEC 13F filings are viewable for Sofinnova Investments going back to 2018
- Sofinnova Investments 2025 Q3 filed Nov. 14, 2025
- Sofinnova Investments 2025 Q2 filed Aug. 14, 2025
- Sofinnova Investments 2025 Q1 filed May 15, 2025
- Sofinnova Investments 2024 Q4 filed Feb. 14, 2025
- Sofinnova Investments 2024 Q3 filed Nov. 13, 2024
- Sofinnova Investments 2023 Q4 restated filed Aug. 15, 2024
- Sofinnova Investments 2024 Q1 restated filed Aug. 14, 2024
- Sofinnova Investments 2024 Q2 filed Aug. 9, 2024
- Sofinnova Investments 2024 Q1 filed May 15, 2024
- Sofinnova Investments 2023 Q3 filed Nov. 14, 2023
- Sofinnova Investments 2023 Q2 filed Aug. 14, 2023
- Sofinnova Investments 2023 Q1 filed May 11, 2023
- Sofinnova Investments 2022 Q4 filed Feb. 14, 2023
- Sofinnova Investments 2022 Q3 filed Nov. 8, 2022
- Sofinnova Investments 2022 Q2 filed Aug. 15, 2022
- Sofinnova Investments 2022 Q1 filed May 16, 2022